MicroRNA: implications in HIV, a brief overview.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4476028)

Published in J Neurovirol on July 23, 2011

Authors

Sudheesh Pilakka-Kanthikeel1, Zainulabedin M Saiyed, Jessica Napuri, Madhavan P N Nair

Author Affiliations

1: Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.

Articles cited by this

MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29

Identification of novel genes coding for small expressed RNAs. Science (2001) 44.44

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58

MicroRNA genes are transcribed by RNA polymerase II. EMBO J (2004) 20.65

Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol (2009) 19.99

The diverse functions of microRNAs in animal development and disease. Dev Cell (2006) 15.62

Identification of virus-encoded microRNAs. Science (2004) 12.56

miRNAs, cancer, and stem cell division. Cell (2005) 12.15

MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68

A cellular microRNA mediates antiviral defense in human cells. Science (2005) 8.48

A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 8.33

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med (2007) 6.01

A role for Dicer in immune regulation. J Exp Med (2006) 5.81

Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64

Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (2007) 5.07

Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum (2008) 4.08

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One (2007) 3.96

Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A (2007) 3.72

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet (2008) 3.27

HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10

Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell (2009) 3.05

MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci (2010) 3.00

Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96

The IFITM proteins inhibit HIV-1 infection. J Virol (2010) 2.80

Striatal microRNA controls cocaine intake through CREB signalling. Nature (2010) 2.56

HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol (2007) 2.20

Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol (2007) 2.11

HIV-1 nef suppression by virally encoded microRNA. Retrovirology (2004) 2.05

Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus (2007) 2.03

MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00

Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun (2005) 1.99

MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96

Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology (2005) 1.95

miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog (2009) 1.94

Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology (2008) 1.87

MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem (2009) 1.74

Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol (2005) 1.46

MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum (2010) 1.45

MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J (2010) 1.39

HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology (2009) 1.35

Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol (2002) 1.29

Host-virus genome interactions: macro roles for microRNAs. Cell Microbiol (2007) 1.28

MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis (2010) 1.26

CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J (2010) 1.23

Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. J Cell Physiol (2008) 1.19

Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol (2002) 1.16

Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions? Retrovirology (2007) 1.12

siRNA, miRNA and HIV: promises and challenges. Cell Res (2005) 1.09

Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol (2010) 1.08

Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. Novartis Found Symp (2004) 1.01

Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One (2010) 1.00

Are viral-encoded microRNAs mediating latent HIV-1 infection? DNA Cell Biol (2006) 0.93

HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem (2008) 0.93

Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1). J Cell Physiol (2008) 0.89

microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection. J RNAi Gene Silencing (2010) 0.85

A balancing act: viruses and miRNAs. J Formos Med Assoc (2008) 0.79

Articles by these authors

Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res (2004) 1.44

Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier. Int J Nanomedicine (2010) 1.31

Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J Neurovirol (2010) 1.16

Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol (2008) 1.16

Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther (2006) 1.11

HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). Neurochem Int (2011) 1.09

Morphine modulates chemokine gene regulation in normal human astrocytes. Clin Immunol (2005) 1.09

Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol (2002) 1.08

Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes. AIDS Res Hum Retroviruses (2009) 1.06

Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 1.05

Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res (2005) 1.00

Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res (2006) 0.99

Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein. AIDS Res Hum Retroviruses (2009) 0.99

Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim Biophys Acta (2007) 0.93

Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 0.93

AZT 5'-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells. J Neurovirol (2009) 0.92

Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS. J Neurovirol (2010) 0.92

HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder. Neurochem Int (2011) 0.90

Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS. J Neurovirol (2011) 0.90

Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder. AIDS Res Treat (2012) 0.86

Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells. Life Sci (2010) 0.86

Combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line. J Basic Clin Physiol Pharmacol (2012) 0.85

HIV infection and drugs of abuse: role of acute phase proteins. J Neuroinflammation (2013) 0.85

A global perspective on HIV/AIDS. Science (2012) 0.83

Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA). Am J Infect Dis (2006) 0.81

Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth. Neoplasia (2005) 0.81

Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr (2013) 0.81

Implications of ER stress, the unfolded protein response, and pro- and anti-apoptotic protein fingerprints in human monocyte-derived dendritic cells treated with alcohol. Alcohol Clin Exp Res (2010) 0.80

Chemopreventive potential of an ethyl acetate fraction from Curcuma longa is associated with upregulation of p57(kip2) and Rad9 in the PC-3M prostate cancer cell line. Asian Pac J Cancer Prev (2012) 0.79

Prostate-Specific Antigen Modulates the Expression of Genes Involved in Prostate Tumor Growth. Neoplasia (2005) 0.78

Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation. Alcohol Clin Exp Res (2009) 0.78

Two step procedure for purification of enzymatically active prostate-specific antigen from seminal plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.77

Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy. Immunol Invest (2003) 0.75

Nanotherapeutics: emerging competent technology in neuroAIDS and CNS drug delivery. Nanomedicine (Lond) (2012) 0.75

Cell cycle checkpoints and pathogenesis of HIV-1 infection: a brief overview. J Basic Clin Physiol Pharmacol (2015) 0.75